Motivation: Early differential diagnosis of parkinsonism-related and unrelated disorders, particularly dementia with Lewy bodies vs Alzheimer's, is crucial for clinical management. Nigrosome 1 (N1) roughly corresponds to the dorsolateral nigral hyperintensity visible on iron-sensitive imaging, aids in identifying early parkinsonian neurodegeneration. Goal(s): Developing an automatic tool for N1 segmentation enhancing diagnostic speed and accuracy for neurodegenerative disorders. Approach: NigrosomeNet employs convolutional neural network, trained and validated on MRI data, to automatically segment N1. Validation included dice similarity comparisons with expert annotations. Results: NigrosomeNet achieved fast and high segmentation accuracy (dice coefficient of 0.96 for parkinsonian patients), showing a significant N1 volume difference between groups. Impact: NigrosomeNet provides a rapid, reliable, and rater-independent solution for N1 analysis, enhancing diagnostic accuracy in clinical settings. This tool could significantly streamline neurodegenerative disease management, support large-scale studies, and reduce the need for specialized training, making early diagnosis more accessible.
No takes yet. Share an insight, caveat, or question.
Mishra et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: